Do not expect dramatic changes yet, this is establishment phase
This is where GHK-Cu can be a fantastic partner to your treatment plan
Taking it before, during, or after a meal will have a negligible, if any, impact on its bioavailability and subsequent effectiveness in a research setting
The delayed release of this product is generally applied to those cases where support is needed in the lower gastrointestinal region as well as when more ongoing needs arise with regard to joint support
BPC-157 is commonly studied in the context of tissue signaling, angiogenesis, gastric biology, nitric oxide modulation, and musculoskeletal tissue research in preclinical models
The Immediate Phase: First 24 to 48 Hours For patients with a significant deficiency, the first couple of days can feel like a meaningful change